Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control studyÁlvaro Beltrán‐Corbellini, Araceli Alonso‐Cánovas, Juan Luis Chico‐García et al.|European Journal of Neurology|2020Cited by 385
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy DrugsEnric Monreal, Luisa María Villar, Manuel Comabella et al.|JAMA Neurology|2023Cited by 51
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, Luisa María Villar, José Ignacio Fernández-Velasco et al.|Brain|2024Cited by 44
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 PatientsVictoria Ros‐Castelló, Jaime Masjuán, Elena Natera‐Villalba et al.|Cerebrovascular Diseases Extra|2020Cited by 20
Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy AdultsAlexander Rodero-Romero, Luisa María Villar, Enric Monreal et al.|International Journal of Molecular Sciences|2024Cited by 20